Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 34

1.

High-dose recombinant Canarypox vaccine expressing HIV-1 protein, in seronegative human subjects.

Goepfert PA, Horton H, McElrath MJ, Gurunathan S, Ferrari G, Tomaras GD, Montefiori DC, Allen M, Chiu YL, Spearman P, Fuchs JD, Koblin BA, Blattner WA, Frey S, Keefer MC, Baden LR, Corey L; NIAID HIV Vaccine Trials Network.

J Infect Dis. 2005 Oct 1;192(7):1249-59. Epub 2005 Aug 31.

PMID:
16136469
[PubMed - indexed for MEDLINE]
Free Article
2.

Cross-reactivity of anti-HIV-1 T cell immune responses among the major HIV-1 clades in HIV-1-positive individuals from 4 continents.

Coplan PM, Gupta SB, Dubey SA, Pitisuttithum P, Nikas A, Mbewe B, Vardas E, Schechter M, Kallas EG, Freed DC, Fu TM, Mast CT, Puthavathana P, Kublin J, Brown Collins K, Chisi J, Pendame R, Thaler SJ, Gray G, Mcintyre J, Straus WL, Condra JH, Mehrotra DV, Guess HA, Emini EA, Shiver JW.

J Infect Dis. 2005 May 1;191(9):1427-34. Epub 2005 Mar 30.

PMID:
15809900
[PubMed - indexed for MEDLINE]
Free Article
3.

Correlation between immunologic responses to a recombinant glycoprotein 120 vaccine and incidence of HIV-1 infection in a phase 3 HIV-1 preventive vaccine trial.

Gilbert PB, Peterson ML, Follmann D, Hudgens MG, Francis DP, Gurwith M, Heyward WL, Jobes DV, Popovic V, Self SG, Sinangil F, Burke D, Berman PW.

J Infect Dis. 2005 Mar 1;191(5):666-77. Epub 2005 Jan 27.

PMID:
15688279
[PubMed - indexed for MEDLINE]
Free Article
4.

Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection.

Flynn NM, Forthal DN, Harro CD, Judson FN, Mayer KH, Para MF; rgp120 HIV Vaccine Study Group.

J Infect Dis. 2005 Mar 1;191(5):654-65. Epub 2005 Jan 27.

PMID:
15688278
[PubMed - indexed for MEDLINE]
Free Article
5.

Attenuated poxvirus-based simian immunodeficiency virus (SIV) vaccines given in infancy partially protect infant and juvenile macaques against repeated oral challenge with virulent SIV.

Van Rompay KK, Abel K, Lawson JR, Singh RP, Schmidt KA, Evans T, Earl P, Harvey D, Franchini G, Tartaglia J, Montefiori D, Hattangadi S, Moss B, Marthas ML.

J Acquir Immune Defic Syndr. 2005 Feb 1;38(2):124-34.

PMID:
15671796
[PubMed - indexed for MEDLINE]
6.

Long-term memory B-cell responses in recipients of candidate human immunodeficiency virus type 1 vaccines.

Evans TG, Frey S, Israel H, Chiu J, El-Habib R, Gilbert P, Gaitan A, Montefiori DC; HIV Vaccine Trials Network (HVTN 803).

Vaccine. 2004 Jun 30;22(20):2626-30.

PMID:
15193388
[PubMed - indexed for MEDLINE]
7.

Comparison of systemic and mucosal delivery of 2 canarypox virus vaccines expressing either HIV-1 genes or the gene for rabies virus G protein.

Wright PF, Mestecky J, McElrath MJ, Keefer MC, Gorse GJ, Goepfert PA, Moldoveanu Z, Schwartz D, Spearman PW, El Habib R, Spring MD, Zhu Y, Smith C, Flores J, Weinhold KJ; National Institutes of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group.

J Infect Dis. 2004 Apr 1;189(7):1221-31. Epub 2004 Mar 15.

PMID:
15031791
[PubMed - indexed for MEDLINE]
Free Article
8.

Moving to human immunodeficiency virus type 1 vaccine efficacy trials: defining T cell responses as potential correlates of immunity.

Russell ND, Hudgens MG, Ha R, Havenar-Daughton C, McElrath MJ.

J Infect Dis. 2003 Jan 15;187(2):226-42. Epub 2003 Jan 6.

PMID:
12552447
[PubMed - indexed for MEDLINE]
Free Article
9.

Estimating cumulative probabilities from incomplete longitudinal binary responses with application to HIV vaccine trials.

Hudgens MG.

Stat Med. 2003 Feb 15;22(3):463-79.

PMID:
12529875
[PubMed - indexed for MEDLINE]
10.

Expression of vaccinia E3L and K3L genes by a novel recombinant canarypox HIV vaccine vector enhances HIV-1 pseudovirion production and inhibits apoptosis in human cells.

Fang ZY, Limbach K, Tartaglia J, Hammonds J, Chen X, Spearman P.

Virology. 2001 Dec 20;291(2):272-84.

PMID:
11878896
[PubMed - indexed for MEDLINE]
Free Article
11.

Safety and immunogenicity of a high-titered canarypox vaccine in combination with rgp120 in a diverse population of HIV-1-uninfected adults: AIDS Vaccine Evaluation Group Protocol 022A.

Gupta K, Hudgens M, Corey L, McElrath MJ, Weinhold K, Montefiori DC, Gorse GJ, Frey SE, Keefer MC, Evans TG, Dolin R, Schwartz DH, Harro C, Graham B, Spearman PW, Mulligan M, Goepfert P; AIDS Vaccine Evaluation Group.

J Acquir Immune Defic Syndr. 2002 Mar 1;29(3):254-61.

PMID:
11873074
[PubMed - indexed for MEDLINE]
12.

A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays.

Currier JR, Kuta EG, Turk E, Earhart LB, Loomis-Price L, Janetzki S, Ferrari G, Birx DL, Cox JH.

J Immunol Methods. 2002 Feb 1;260(1-2):157-72.

PMID:
11792386
[PubMed - indexed for MEDLINE]
13.

Development and validation of a gamma interferon ELISPOT assay for quantitation of cellular immune responses to varicella-zoster virus.

Smith JG, Liu X, Kaufhold RM, Clair J, Caulfield MJ.

Clin Diagn Lab Immunol. 2001 Sep;8(5):871-9.

PMID:
11527795
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Use of overlapping peptide mixtures as antigens for cytokine flow cytometry.

Maecker HT, Dunn HS, Suni MA, Khatamzas E, Pitcher CJ, Bunde T, Persaud N, Trigona W, Fu TM, Sinclair E, Bredt BM, McCune JM, Maino VC, Kern F, Picker LJ.

J Immunol Methods. 2001 Sep 1;255(1-2):27-40.

PMID:
11470284
[PubMed - indexed for MEDLINE]
15.

Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteers.

Belshe RB, Stevens C, Gorse GJ, Buchbinder S, Weinhold K, Sheppard H, Stablein D, Self S, McNamara J, Frey S, Flores J, Excler JL, Klein M, Habib RE, Duliege AM, Harro C, Corey L, Keefer M, Mulligan M, Wright P, Celum C, Judson F, Mayer K, McKirnan D, Marmor M, Woody G; National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group and HIV Network for Prevention Trials (HIVNET).

J Infect Dis. 2001 May 1;183(9):1343-52. Epub 2001 Apr 10.

PMID:
11294665
[PubMed - indexed for MEDLINE]
Free Article
16.

Cellular and humoral immune responses to a canarypox vaccine containing human immunodeficiency virus type 1 Env, Gag, and Pro in combination with rgp120.

AIDS Vaccine Evaluation Group 022 Protocol Team.

J Infect Dis. 2001 Feb 15;183(4):563-70. Epub 2001 Jan 18.

PMID:
11170981
[PubMed - indexed for MEDLINE]
Free Article
17.

Immunization with recombinant canarypox vectors expressing membrane-anchored glycoprotein 120 followed by glycoprotein 160 boosting fails to generate antibodies that neutralize R5 primary isolates of human immunodeficiency virus type 1.

Bures R, Gaitan A, Zhu T, Graziosi C, McGrath KM, Tartaglia J, Caudrelier P, El Habib R, Klein M, Lazzarin A, Stablein DM, Deers M, Corey L, Greenberg ML, Schwartz DH, Montefiori DC.

AIDS Res Hum Retroviruses. 2000 Dec 10;16(18):2019-35.

PMID:
11153085
[PubMed - indexed for MEDLINE]
18.

Phase I clinical trial of a recombinant canarypoxvirus (ALVAC) vaccine expressing human carcinoembryonic antigen and the B7.1 co-stimulatory molecule.

Hörig H, Lee DS, Conkright W, Divito J, Hasson H, LaMare M, Rivera A, Park D, Tine J, Guito K, Tsang KW, Schlom J, Kaufman HL.

Cancer Immunol Immunother. 2000 Nov;49(9):504-14.

PMID:
11092617
[PubMed - indexed for MEDLINE]
19.

A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with rgp120 elicits broad and durable CD8+ cytotoxic T lymphocyte responses in seronegative volunteers.

Evans TG, Keefer MC, Weinhold KJ, Wolff M, Montefiori D, Gorse GJ, Graham BS, McElrath MJ, Clements-Mann ML, Mulligan MJ, Fast P, Walker MC, Excler JL, Duliege AM, Tartaglia J.

J Infect Dis. 1999 Aug;180(2):290-8.

PMID:
10395842
[PubMed - indexed for MEDLINE]
Free Article
20.

A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals.

Larsson M, Jin X, Ramratnam B, Ogg GS, Engelmayer J, Demoitie MA, McMichael AJ, Cox WI, Steinman RM, Nixon D, Bhardwaj N.

AIDS. 1999 May 7;13(7):767-77.

PMID:
10357375
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk